Blog | NFXF

Authors: Hidayat Y. Ogunsola, April D. Summers, Maria G. Gonzalez, Angela M. Thompson-Paul, Marc Schweizer, Robert M. Miller, Hilary Rosselot, Sarah C. Tinker[1]

At Mirum Pharmaceuticals, our work begins with a simple belief: people living with rare conditions deserve urgency, commitment, and meaningful scientific progress.

Mirum is a rare disease company focused on developing and delivering medicines for conditions where the burden is profound, and the need for new options is significant. Our areas of focus include rare liv...

Authors: Vivian Chen, Marisa Vomvos, Anna De Sonia, Hilary Rosselot, Reymundo Lozano 

Read the article published in

Talk Presented by: Dr. Nisha Raj, the PI of the Karim’s lab
Summarized by: Hungoo Lee, Assistant Professor, Department of Genetic Medicine, Johns Hopkins School of Medicine

Summary

Dr. Nisha Raj lab in Emory studied the difference in RNA and Protein ...

Aberrant Neural Entrainment to Word-Level Speech Patterns in Fragile X Syndrome: Evidence for a Statistical Learning Deficit

Authors: Laura Batterink, Yanchen Liu, Grace Westerkamp, Jae Citarella, Peyton Siekierski, Lynxie Voorhees, Lauren E Ethridge, Elizabeth Smith, Rana Elmaghraby, Craig A Erickson, Zag ElSayed, Anubhuti Goel, Steve W Wu, and Ernest V P...